146 related articles for article (PubMed ID: 26022558)
1. Estimating the concordance probability in a survival analysis with a discrete number of risk groups.
Heller G; Mo Q
Lifetime Data Anal; 2016 Apr; 22(2):263-79. PubMed ID: 26022558
[TBL] [Abstract][Full Text] [Related]
2. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
3. Estimating a time-dependent concordance index for survival prediction models with covariate dependent censoring.
Gerds TA; Kattan MW; Schumacher M; Yu C
Stat Med; 2013 Jun; 32(13):2173-84. PubMed ID: 23172755
[TBL] [Abstract][Full Text] [Related]
4. Estimating twin concordance for bivariate competing risks twin data.
Scheike TH; Holst KK; Hjelmborg JB
Stat Med; 2014 Mar; 33(7):1193-204. PubMed ID: 24132877
[TBL] [Abstract][Full Text] [Related]
5. Concordance for prognostic models with competing risks.
Wolbers M; Blanche P; Koller MT; Witteman JC; Gerds TA
Biostatistics; 2014 Jul; 15(3):526-39. PubMed ID: 24493091
[TBL] [Abstract][Full Text] [Related]
6. Prioritized concordance index for hierarchical survival outcomes.
Cheung LC; Pan Q; Hyun N; Katki HA
Stat Med; 2019 Jul; 38(15):2868-2882. PubMed ID: 30957257
[TBL] [Abstract][Full Text] [Related]
7. Regression models for the restricted residual mean life for right-censored and left-truncated data.
Cortese G; Holmboe SA; Scheike TH
Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
[TBL] [Abstract][Full Text] [Related]
9. Addressing issues associated with evaluating prediction models for survival endpoints based on the concordance statistic.
Wang M; Long Q
Biometrics; 2016 Sep; 72(3):897-906. PubMed ID: 26756274
[TBL] [Abstract][Full Text] [Related]
10. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy.
Punnen S; Freedland SJ; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Carroll PR; Cooperberg MR
Eur Urol; 2014 Jun; 65(6):1171-7. PubMed ID: 23587869
[TBL] [Abstract][Full Text] [Related]
11. Quantile regression models for survival data with missing censoring indicators.
Qiu Z; Ma H; Chen J; Dinse GE
Stat Methods Med Res; 2021 May; 30(5):1320-1331. PubMed ID: 33826461
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the Most Influential Factors for Survival Probability Prediction of Prostate Cancer Patients.
Stanković J; Stanković M
Cancer Invest; 2017 Oct; 35(9):594-600. PubMed ID: 29064739
[TBL] [Abstract][Full Text] [Related]
13. Impact of censoring on learning Bayesian networks in survival modelling.
Stajduhar I; Dalbelo-Basić B; Bogunović N
Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
[TBL] [Abstract][Full Text] [Related]
14. A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.
Hsu CH; Taylor JM
Stat Med; 2010 Sep; 29(21):2215-23. PubMed ID: 20812302
[TBL] [Abstract][Full Text] [Related]
15. Biopsy features associated with prostate cancer progression in active surveillance patients: comparison of three statistical models.
Iremashvili V; Manoharan M; Rosenberg DL; Soloway MS
BJU Int; 2013 Apr; 111(4):574-9. PubMed ID: 22564446
[TBL] [Abstract][Full Text] [Related]
16. Estimating lifetime or episode-of-illness costs under censoring.
Basu A; Manning WG
Health Econ; 2010 Sep; 19(9):1010-28. PubMed ID: 20665908
[TBL] [Abstract][Full Text] [Related]
17. Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier.
Gabriele D; Jereczek-Fossa BA; Krengli M; Garibaldi E; Tessa M; Moro G; Girelli G; Gabriele P;
Radiat Oncol; 2016 Feb; 11():23. PubMed ID: 26911291
[TBL] [Abstract][Full Text] [Related]
18. Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy.
Pond GR; Armstrong AJ; Wood BA; Leopold L; Galsky MD; Sonpavde G
BJU Int; 2012 Dec; 110(11 Pt B):E461-8. PubMed ID: 22520631
[TBL] [Abstract][Full Text] [Related]
19. Selection Bias Due to Loss to Follow Up in Cohort Studies.
Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
[TBL] [Abstract][Full Text] [Related]
20. About an adaptively weighted Kaplan-Meier estimate.
Plante JF
Lifetime Data Anal; 2009 Sep; 15(3):295-315. PubMed ID: 19533346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
